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Edited by Jesus AvilaAbstract To overcome positional and methylation eﬀects on
transgene expression, we developed a universal cloning cassette
for in vivo assessment of regulatory elements using the luciferase
reporter gene and the CCCD camera. Monitoring luciferase
expression pattern in live mice enables screening of large num-
bers of transgenic founders quickly and inexpensively. We dem-
onstrate that in the engineered transgenic mice, the chicken b-
globin 5 0HS4 insulator did not always provide the desirable
expression pattern, and the Island Element, responsible for the
demethylation of the surrounding DNA region, was not beneﬁ-
cial. Both tested liver-speciﬁc and developmentally regulated
promoters exhibited the expected expression pattern in most
transgenic founders.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Genetically modiﬁed mice, including transgenic animals,
serve as important models of human diseases. However, stable
transgene expression in transgenic mice depends on many fac-
tors and is diﬃcult to achieve in some cases [1,2]. Unstable
transgene expression can be a result of a ‘position eﬀect’, which
is caused by the inﬂuence of the genomic environment on the
transgene expression in the site of transgene integration [3,4].
Diﬀerent host factors may also silence transgene expression
by hypermethylation [1].
The goal of this study was to develop tools for generation of
transgenic mice and for testing regulatory elements that should
enhance the eﬃciency of transgenic mouse production. We
generated expression cassettes carrying regulatory elements
that would drive methylation resistant, position-independent
transgene expression. In this work, the expression was also
designed to be liver-speciﬁc and developmentally regulated.
In order to overcome the ‘position eﬀect’, we ﬂanked the
desirable transgene by the chicken b-globin 5 0HS4 insulators.
Chromatin insulators, also known as boundary elements, are
DNA sequences capable of suppressing the position eﬀect by
blocking the action of distant enhancers and other regulatory
elements; moreover, they can shield a locus from repressive ef-
fects of ﬂanking chromatin. The presence of insulators eﬀec-
tively increases the yield of phenotypically desirable*Corresponding author. Fax: +972 2 6430982.
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doi:10.1016/j.febslet.2007.07.029transgenic mice obtained from each integration session [3–5].
The chicken b-globin 5 0HS4 element has been shown to func-
tion as a typical insulator, shielding transgenes from position
eﬀects [6].
In order to prevent transgene methylation, we used the Is-
land Element (IE), which was found to protect itself and ﬂank-
ing sequences from de novo methylation, when placed
upstream of a promoter [7,8]. We inserted the IE between
the promoter and transgene, in order to obtain protection
from methylation for both of them.
To obtain liver-speciﬁc expression, two liver-speciﬁc pro-
moters were applied: the human serum amyloid protein
(SAP) promoter [2,9] or the mouse major urinary protein
(MUP) promoter [10,11]. Both of these promoters are
expressed only after birth, thus preventing transgene expres-
sion at the pre-natal stages. This approach helps avoid poten-
tial transgene interference with embryonic developmental
programs and reduce immune tolerance to the transgene.
Using the luciferase gene as a reporter enabled monitoring of
its expression in vitro, in vivo, and in transgenic mice. In vivo
activity and expression pattern of the transgenic lines were
monitored by the CCCD camera [12], which provides quanti-
tative bioluminescence imaging of live mice [13,14]. This quick
and inexpensive method also enabled us to screen large num-
bers of transgenic founders for the desirable expression pat-
tern. We conﬁrmed the postnatal expression of the reporter
transgene and determined liver speciﬁcity, duration and inten-
sity of its expression in diﬀerent founders. This study demon-
strates a non-invasive method of monitoring tissue-speciﬁc
expression of a transgene, as well as utility of the tested regu-
latory elements for generation of transgenic mice.2. Materials and methods
2.1. Plasmid construction
The pNH12 (Fig. 1A) was derived from pJC-13 (provided by Prof.
Felsenfeld), which contains two duplicates of the 1.2 kbp chicken
b-globin insulator [6]. First, we removed the Neo gene and the enhan-
cer sequences to create the pISUL. Second, we inserted artiﬁcially syn-
thesized DNA fragments containing sites for rare restriction enzymes
(AscI, PacI, FseI, SﬁI) ﬂanking the insulator repeats in the pINSUL
plasmid; the resulting construct (pNH12) was used as a general cassette
for insertion of speciﬁc genes at BamHI site between duplicate copies
of the chicken b-globin insulator.
The SAP (human serum amyloid protein) promoter was ﬁrst
cloned from the pSAP5-3V (provided by Dr. Yamamura [2] into
the pBS-ssp plasmid (which was constructed by deleting the F1 frag-
ment between SspI sites in the pBS-SK (Stratagene, Cedar Creek,
TX, USA))) at EcoRI–SalI sites. Then it was excised at the XbaI–
XhoI sites and cloned upstream the luciferase gene in the pGL3 basic
plasmid (Promega, Madison, WI, USA) at NheI–XhoI sites. The
resulting plasmid was called pSAP-LUC (pSL). The IE, kindly pro-
vided by Prof. Cedar [8], was inserted between the SAP promoterblished by Elsevier B.V. All rights reserved.
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Fig. 1. Generation of expression cassettes. (A) The universal cloning cassette for transgene expression. INS – chicken b-globin 5 0HS4 insulator
(1.2 kbp), RCS – rare cleavage sites (AscI, PacI, FseI, SﬁI). BamHI – cloning site for transgene insulators. (B) The four constructed expression
cassettes: ﬁreﬂy luciferase reporter gene (luc) under the control of liver-speciﬁc developmentally regulated SAP (serum amyloid protein) or MUP
(major urinary protein) promoters, polyA – SV40 polyA, IE – Island element sequence, INS – chicken b-globin 5 0HS4 insulator (1.2 kbp).
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plasmid. The MUP (mouse major urinary protein) promoter was
cloned from the p11AS-SV40-7 (provided by Prof. Rogler [10]) into
pBS-ssp at PstI–XbaI sites, then cut by EcoRI–NotI sites and
inserted into pCDNA3.1 (Invitrogen, Frederick, MD, USA) to create
pcDNA-MUP. The pMUP-LUC (pML) was created by cutting the
MUP promoter from pcDNA-MUP at KpnI–XhoI sites and its
cloning upstream the luciferase gene into the pGL3 basic plasmid
(Promega, Madison, WI, USA). The pMLIE was created by replac-
ing the SAP promoter from pSLIE with the MUP promoter at
KpnI–XhoI sites. The BamHI fragments from all four plasmids –
pML, pMLIE, pSL, pSLIE – contained the promoter and the lucif-
erase gene, with or without IE, and were inserted into the pNH12
cassette to create: pNH-ML, pNH-MI, pNH-SL, pNH-SI, respec-
tively (Fig. 1B). All plasmids were propagated in either JM109 or
XL1B strains, and puriﬁed using the Qiagen plasmid puriﬁcation
kits (Hilden, Germany).2.2. Transfections and in vitro activity assays
AML12 cells (non-transformed mouse hepatocytes) [15] were tran-
siently transfected with luciferase expressing plasmids. Cells were
seeded at 0.5 · 105 cells/ml in 12-well plates; growing medium: 1:1
DMEM/HAM’s F-12 medium + 10% FCS, 1% pen/strep, 1% ITS-G
(insulin–transferrin–selenium; all reagents – from Biological Industries
Co., Beit Haemek, Israel), and 40 ng/ml dexamethasone (Sigma, St.
Louis, MO, USA). After 24 h, cells were transfected with 0.27 lg of
each plasmid: pNH-ML, pNH-MI, pNH-SL, pNH-SI or pGL3p (Pro-
mega, Madison, WI, USA) as a control. Each transfection mixture
contained also 0.03 lg of pRL plasmid (Promega, Madison, WI,
USA) that expresses Renilla Luciferase, to normalize the results. The
transfections were performed using the Fugene 6 transfection reagent
(Roche Diagnostics, Basel, Switzerland).
Luciferase activity in vitro: Fireﬂy luciferase activity was measured
24 h after transfection. Cell lysis and luciferase reactions were
carried out using the Dual-Luciferase Reporter Assay (Promega,
Madison, WI, USA) according to the manufacturer’s instructions.
The activity was normalized to the Renilla luciferase activity from
pRL plasmid.2.3. Mice
Mice were maintained at the Animal Facility of the Hebrew Univer-
sity Medicine School in a speciﬁc pathogen-free unit, under a 12 h
light/dark cycle, and were provided with food and water ad libidum.
The Institutional Animal Care and Use Committee approved all pro-
cedures. DNA puriﬁcation from mouse tails was performed using
either the Wizard Genomic DNA puriﬁcation kit (Promega, Madi-
son, WI, USA) or the Purgene DNA isolation kit (Gentra systems,
Minneapolis, MN, USA).
2.4. Hydrodynamic tail-vein injections
In each experiment, 50 lg/1.5 ml PBS of plasmid DNA was tail vein
injected at high pressure into three Balb/c mice. The total volume was
injected rapidly, over 5–8 s, into the tail-vein of a mouse, using a 27-
gauge needle. Luciferase activity was monitored by CCCD camera
after 24 h, as described below.
2.5. Generation of luciferase transgenic mice
Transgenic animals were produced at the Transgenic Unit of the
Animal Facility of the Hebrew University Medical School.
Preparation of DNA for microinjection. The appropriate transgene
DNA fragments were excised from the vectors (pNH-ML, pNH-MI,
pNH-SL, pNH-SI) with three restriction enzymes: AscI, PacI, SﬁI,
electrophoresed on 1% agarose gel and the isolated band (puriﬁed by
with the Qiagen gel extraction kit (Hilden,Germany)) was next puri-
ﬁed on an ion exchange column (Elutip-D column, Schleicher &
Schuell, Germany) with Millex-HV 0.45lm ﬁlter (Millipore, Billerica,
MA, USA). The puriﬁed fragment was ethanol precipitated, dissolved
in the injection buﬀer (7.5 mM Tris, 0.2 mM EDTA, pH 7.5) to a ﬁnal
concentration of 15 ng/ll and injected into a pronucleus of a fertilized
egg derived from (C57Black · BALB/c) F1 mice. Embryos at the two-
cell stage were transferred into the oviducts of pseudopregnant F1 fe-
males. Founder animals were identiﬁed by PCR analysis of tail DNA
and conﬁrmed by Southern blot analysis. Primers for PCR: luciferase
sense: 5 0-gagaattacacggcgatctttc, luciferase antisense: 5 0-gag-
gttccatctgccaggta, IE sense: 5 0-cgccgctcgagatccttagggagcgatcca, IE
antisense: 5 0-ccctaaggaagcttccagcaaatgcgttac. When the luciferase
PCR fragment (650 bp) was used as a hybridization probe, it was
Luciferase expression in vitro 
100
33.5
17 15
0
10
20
30
40
50
60
70
80
90
100
pGL3p pNH-SL pNH-SI pNH-ML pNH-MI
Lu
c
 
ex
pr
es
si
on
 (%
 fr
o
m
 c
o
n
tr
o
l)
Luciferase expression in vivo
0
20
40
60
80
100
120
pGL3p   pNH-SL pNH-SI pNH-ML pNH-MI
Lu
c 
ex
pr
es
si
on
 (%
 fr
o
m
 c
o
n
tr
o
l)
A
B
Fig. 2. Assessment of constructed expression cassettes using the
luciferase reporter gene. (A) In vitro assessment of expression cassettes
after transient transfection to cells: AML12 cells were transiently
transfected with the four expression cassettes and luciferase activity
was measured after 24 h. The graph represents results (±S.D.) of three
separate experiments, each one made in triplicates relative to the
control plasmid, pGL3p. The luciferase activity was normalized to
internal pRL control plasmid (see Section 2). The designated plasmids
are described in Fig. 1B. (B) In vivo assessment of expression cassettes:
transient in vivo expression after tail vein injection of diﬀerent
cassettes: plasmid DNA was tail vein injected at high pressure into
three Balb/c mice. Luciferase activity was monitored by CCCD camera
after 24 h, as described in Section 2. The graph represents results from
one experiment done in triplicates normalized to control plasmid,
pGL3p. The designated plasmids are described in Fig. 1B.
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Industries Co., Beit Haemek, Israel), according to manufacturer’s
instructions.
2.6. In vivo transgenic monitoring by the CCCD camera
Mice that were PCR positive for the presence of luciferase trans-
gene were screened by the CCCD camera to evaluate and monitor
luciferase expression, as described previously [12]. A pseudocolor im-Table 1
Pattern of transgene expression in 1st (A) and 2nd (B) generation transgenic
Name Promoter IE # of Mice Transgene presenc
(A) DNA construct First generation
NHML MUP  64 2 (3.1%)
NHMI MUP + 85 15 (17%)
NHSL SAP  55 5 (9%)
(B) DNA construct Second generation
NHML MUP  0 
NHMI MUP + 29 NM
NHSL SAP  25a 7 (28%)
9b 4 (44%)
NM: not measured, mice were screened only by the CCCD camera.
aProgeny of NHSL transgenic male.
bProgeny of NHSL transgenic female.age (Fig. 3A and B) represents light-intensity (blue being the least in-
tense, and red being the most intense). The integration light was, in
all cases, the result of a 2-min exposure and acquisition. Recorded
measurements were the total sum of integrated signals, subtracted
from the background area of equal size. In all experiments, mice were
anesthetized before light detection, with 0.2–0.3 ml of 4% chloral hy-
drate (Sigma–Aldrich, Steinheim, Switzerland). Five minutes before
monitoring light emission, the animals were injected IP with Beetle
luciferin (Promega, Madison, WI, USA) in PBS (126 mg/kg body
weight).3. Results and discussion
3.1. Generation of a universal gene expression cassette
First, we constructed a universal cassette for transgene
expression (pNH12) which enabled cloning of any desired gene
(at BamHI site) between duplicates of chicken b-globin insula-
tor [6] (Fig. 1A). Two identical sequences of four rare restric-
tions enzymes sites (AscI, PacI, FseI, SﬁI) were inserted to
ﬂank the insulators duplicates, in order to alleviate cut oﬀ of
the whole construct with the desired transgene, for its injection
into fertilized egg.
3.2. Cloning the luciferase reporter gene and the liver-speciﬁc
promoters into the universal expression cassette
The four diﬀerent variants containing the luciferase reporter
gene under the control of two diﬀerent promoters, each with or
without IE, were constructed (Fig. 1B). The luciferase gene
from pGL3 basic plasmid was cloned under the regulation of
one of the two liver-speciﬁc promoters: the human serum amy-
loid protein (SAP) promoter [2,9] or the mouse major urinary
protein (MUP) promoter [10,11]; the products were designated
pNH-SL and pNH-ML, respectively. Their variants which car-
ried also the IE [8] between the promoter and the reporter gene
were designated pNH-SI and pNH-MI, respectively. All four
constructs were inserted into the universal expression cassette
pNH12 under the same names (Fig. 1B).
3.3. In vitro assessment of the expression vectors
Measurements of luciferase activity of the generated expres-
sion cassettes in vitro following transient transfection of
AML12 cells demonstrated that plasmids carrying the IE
exhibited higher activity (Fig. 2A). Thus, insertion of the IE
did not only interfere with transient expression in vitro, but
even enhanced it. Both tested liver-speciﬁc promoters provided
similar expression levels.mice
e (PCR) Luciferase expression Liver-speciﬁc expression
2 (3.1%) 1 (1.5%)
2 (2.3%) 1 (1.2%)
3 (5.4%) 2 (3.6%)
 
9 (31%) 2 (7%)
7 (28%) 7 (28%)
4 (44%) 2 (22%)
60
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Prior to the generation of the transgenic mice, we decided to
test the expression of the generated expression cassettes in vivo
in the mouse liver using the hydrodynamic tail vein injection
method [16]. Luciferase activity was measured after luciferin
injection and animal exposure to the CCCD camera
(Fig. 2B). The results of transient in vivo expression demon-
strated that: (a) the diﬀerence between control plasmid pGL3p
and the tested vectors became less signiﬁcant and (b) IE
decreased the expression level.0
10
20
30
40
50
223.52.5
NH-SL (f)NH-SL (m)NH-MINH-ML
In
te
gr
at
ed
 li
gh
t u
ni
ts
 (X
10
*6
)
Ages,
month:
Construct:
0
10
20
30
40
50
60
70
80
2.5 8 11 14 3.5 4.5 6 7 2 5 12 14 24
In
te
gr
at
ed
 
lig
ht
 
u
n
its
 (X
10
*6
)
Age, month:
NH-ML (m) NH-MI (m) NH-SL (m)Construct:
C
D
Fig. 3. Luciferase expression in transgenic mice. (A) an example for
liver-speciﬁc luciferase expression (transgenic mouse with NH-ML
cassette). (B) An example of non-speciﬁc luciferase expression (trans-
genic mouse with NH-MI cassette). Images (A,B) are overlaid on
pictures from the CCCD camera. A pseudocolor scale represents light-
intensity. (C) First measurements of Luciferase expression in the ﬁrst
generation of transgenic mice as determined by the CCCD camera, at
ages as indicated ((f) stand for female and (m) for male). (D) Kinetics
of luciferase expression in transgenic males. Luciferase expression in
diﬀerent transgenic lines was monitored at diﬀerent time points, as
indicated. Each color represents one mouse ((m) stands for male).3.5. Generation of transgenic mice and assessment of transgene
expression
Transgenic mice were generated as described in Methods.
The data on generated animals are summarized in Table 1.
The NH-MI mice (see Fig. 1B): 85 ﬁrst generation mice
born after microinjection of the NH-MI fragment (see
Fig. 1B) were overall analyzed. Veriﬁcation of the transgene
presence by PCR demonstrated that 15 mice were positive.
These mice were screened for luciferase expression by the
CCCD camera. Out of 15 tested mice, two males expressed
luciferase, however, only one displayed liver-speciﬁc expres-
sion pattern (Fig. 3A). The presence of the luciferase gene
in these two mice was conﬁrmed also by Southern blot
hybridization with a luciferase probe (data not shown). In or-
der to verify the inheritance pattern of the transgene in the
next generation, and to prove the absence of luciferase
expression in embryos, the transgenic male was bred with
CB6/F1 females. Pregnant mothers were photographed with
the CCCD camera in the second week of pregnancy, and
no light emission was detectable. Among the progeny of this
male (19 mice), nine were PCR positive for the luciferase
gene, among these, two demonstrated liver-speciﬁc postnatal
luciferase expression.
The NH-ML mice (see Fig. 1B): 64 founders were analyzed;
among these, two were positive by PCR. In both of these mice,
although luciferase expression was also detected by the CCCD
camera, only one mouse demonstrated liver-speciﬁc expression
pattern; since this latter mouse was not reproductive, we could
not study its inheritance pattern.
The NH-SL mice (see Fig. 1B): 55 mice were generated in
the ﬁrst generation; among these, ﬁve were positive by PCR.
These ﬁve mice were screened for luciferase expression by
the CCCD camera: only three of them expressed luciferase,
and only in two mice (male and female) was this expression
liver-speciﬁc. For the second generation, these two mice were
bred with CB6/F1 partners. The females that were bred with
a transgenic male were screened for luciferase expression in
the second week of pregnancy: no luciferase expression was
detected. Among his progeny (25 mice): seven were PCR po-
sitive for the luciferase transgene, and all seven demon-
strated liver-speciﬁc luciferase expression (Table 1B).
Among the transgenic female’s progeny (nine mice): four
were PCR positive for the luciferase gene; all four expressed
luciferase, however, in only two was its expression liver-spe-
ciﬁc (Table 1B).
The NH-SI mice (see Fig. 1B): After comparing the results
from the two lines expressing luciferase under the MUP pro-
moter with or without IE (NH-ML vs. NH-MI), we concluded
that the insertion of the IE did not confer any advantage for
gene expression pattern in the transgenic mice. As a result,we did not generate transgenic mice with luciferase under the
SAP promoter and the IE.
The expression level of luciferase in each transgenic mouse
was measured at 2–3 months of age for the ﬁrst time
(Fig. 3C). The kinetics of luciferase expression in the ﬁrst gen-
eration of transgenic mice was also followed during the animal’s
life (Fig. 3D). The age-dependent reduction of transgene
expression may reﬂect the natural pattern of expression of the
tested promoters: for example, such reduction of MUP2
mRNA expression in murine liver was reported previously [17].
In conclusion, we have constructed a universal cassette for
transgene expression. In our constructs, insulators did not pro-
vide high uniformity of transgene expression (tissue speciﬁc-
ity), or high frequency of desirable transgene expression
3990 N. Klopstock et al. / FEBS Letters 581 (2007) 3986–3990pattern (Fig. 3 and Table 1). These results are consistent with
those of others indicating that the eﬀect of insulators is not
universal, but rather construct-dependent [18,19]. The IE lo-
cated between promoter and the reporter did not confer any
advantage to transgene expression in vivo. Although both
tested promoters enabled a postnatal onset of luciferase
expression in all transgenic lines, liver speciﬁcity was not al-
ways achieved (Fig. 3C). All tested constructs demonstrated
prolonged expression of the reporter transgene without
changes in tissue distribution during animal life. The NH-SL
transgene (SAP promoter without IE) showed the best pattern
of expression and the highest eﬃciency of transgenesis; this
construct may be the vector of choice for the generation of
transgenic mice with developmentally regulated, liver-speciﬁc
expression of a desired transgene.
The use of the CCCD camera allowed us to monitor the
expression of the luciferase transgene in live transgenic mice,
and to compare expression patterns, both qualitatively and
quantitatively, in diﬀerent mice with an easy, quick and inex-
pensive system. Remarkably, with the aid of the CCCD cam-
era, we were able to detect non-speciﬁc transgene expression
in those tissues which are usually not tested by standard meth-
ods (Fig. 3C). In addition, this approach enabled us to visual-
ize ongoing monitoring of gene expression through repeated
imaging of luciferase bioluminescence.
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